Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis.

Optic perineuritis aquaporin-4 (AQP4) myelin oligodendrocyte glycoprotein (MOG) optic nerve sheath optic neuritis

Journal

Neuro-ophthalmology (Aeolus Press)
ISSN: 0165-8107
Titre abrégé: Neuroophthalmology
Pays: England
ID NLM: 8408966

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 05 03 2019
revised: 04 04 2019
accepted: 11 04 2019
pmc-release: 28 05 2020
entrez: 21 2 2020
pubmed: 23 2 2020
medline: 23 2 2020
Statut: epublish

Résumé

Optic perineuritis can be a manifestation of infectious and systemic inflammatory disorders, but the majority of cases are idiopathic. Myelin oligodendrocyte glycoprotein (MOG)-IgG-positive optic neuritis has been reported to be associated with optic nerve sheath enhancement. This report describes two MOG-IgG patients with clinical, radiological and therapeutic response consistent with optic perineuritis. MOG-IgG may account for many cases of previously described idiopathic optic perineuritis. Vision loss with optic nerve sheath enhancement on MRI should prompt testing for MOG-IgG.

Identifiants

pubmed: 32076441
doi: 10.1080/01658107.2019.1607883
pii: 1607883
pmc: PMC6999618
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1-4

Informations de copyright

© 2019 Taylor & Francis Group, LLC.

Références

Am J Ophthalmol. 2018 Nov;195:8-15
pubmed: 30055153
Arch Ophthalmol. 2001 Sep;119(9):1299-306
pubmed: 11545635
Ophthalmology. 2018 Oct;125(10):1628-1637
pubmed: 29716788
Int Med Case Rep J. 2017 Jun 08;10:181-188
pubmed: 28652823
JAMA Neurol. 2018 Nov 1;75(11):1355-1363
pubmed: 30014148
Neurol Neuroimmunol Neuroinflamm. 2014 Oct 29;1(4):e40
pubmed: 25364774

Auteurs

A Sebastian Lopez-Chiriboga (AS)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota , USA.

Gregory Van Stavern (G)

Department of Ophthalmology and Visual Sciences and Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.

Eoin P Flanagan (EP)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota , USA.
Laboratory Medicine, and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Sean J Pittock (SJ)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota , USA.
Laboratory Medicine, and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

Jim Fryer (J)

Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota , USA.
Laboratory Medicine, and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

M Tariq Bhatti (MT)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

John J Chen (JJ)

Departments of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

Classifications MeSH